The stock has been consolidating for a while now and also the vaccine favors the stock. Long entry for a target of 206 (short term), 345 for medium-term (3 months). Maintain an SL of 171 for short term.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.